KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Non-Current Assets: 2015-2025

Historic Non-Current Assets for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to $2.0 billion.

  • BeOne Medicines' Non-Current Assets rose 2.55% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 2.55%. This contributed to the annual value of $1.9 billion for FY2024, which is 20.44% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Non-Current Assets is $2.0 billion, which was down 1.01% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Non-Current Assets ranged from a high of $2.0 billion in Q2 2025 and a low of $680.0 million during Q1 2021.
  • In the last 3 years, BeOne Medicines' Non-Current Assets had a median value of $1.9 billion in 2024 and averaged $1.7 billion.
  • Data for BeOne Medicines' Non-Current Assets shows a peak YoY soared of 57.82% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows BeOne Medicines' Non-Current Assets stood at $921.6 million in 2021, then grew by 27.19% to $1.2 billion in 2022, then spiked by 36.65% to $1.6 billion in 2023, then rose by 20.44% to $1.9 billion in 2024, then rose by 2.55% to $2.0 billion in 2025.
  • Its Non-Current Assets stands at $2.0 billion for Q3 2025, versus $2.0 billion for Q2 2025 and $1.9 billion for Q1 2025.